EverSource Wealth Advisors’s Verona Pharma VRNA Stock Holding History

EverSource Wealth Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,974	Closed	-$211K	–	4461
2025 Q3	$211K	Sell	1,974 -82	-4%	-$8.56K	0.01%	877
2025 Q2	$194K	Sell	2,056 -230	-10%	-$17K	0.01%	876
2025 Q1	$145K	Sell	2,286 -3,872	-63%	-$232K	0.01%	775
2024 Q4	$286K	Buy	6,158 +5,964	+3,074%	+$224K	0.02%	522
2024 Q3	$5.58K	Buy	+194	New	+$4.77K	﹤0.01%	2182
2024 Q1	–	Sell	-295	Closed	-$5.87K	–	2998
2023 Q4	$5.87K	Buy	+295	New	+$4.36K	﹤0.01%	1796

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

EverSource Wealth Advisors's VRNA Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,974 shares — an estimated $211K sold.

EverSource Wealth Advisors first reported a position in VRNA in Q4 2023 and held it in 6 quarters. The position peaked at $286K in Q4 2024. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

EverSource Wealth Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 1,974 Verona Pharma shares in Q4 2025, an estimated $211K.
EverSource Wealth Advisors first reported a position in Verona Pharma in Q4 2023 and held it in 6 quarters.
EverSource Wealth Advisors's Verona Pharma position peaked at $286K in Q4 2024.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.